Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,444.00    14.00 (0.32%)
Bid:
4,440.00
Ask:
4,446.00
Spread: 6.00 (0.135%)
Market Cap: £2.07b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Statement re Analyst Presentation

2 Dec 2009 09:09

RNS Number : 4473D
Morgan Sindall PLC
02 December 2009
 



Morgan Sindall plc

2 December 2009

Analyst/Investor Presentation

Morgan Sindall plc (the 'Company') will this afternoon host a presentation for analysts and investors on the Company's Investment division.

A trading update was provided in the Company's Interim Management Statement which was released on 10 November 2009 and no further comments on current trading will be made during today's presentation.

A copy of the presentation will be made available on the Company's website, www.morgansindall.co.uk

- Ends -

ENQUIRIES:

Morgan Sindall plc Tel: 020 7307 9200

Paul Smith, Chief Executive

David Mulligan, Finance Director

Blythe Weigh Communications Tel: 020 7138 3204

Tim Blythe Mobile: 07816 924626

Editor's notes:

Morgan Sindall plc is a top UK construction and regeneration group which operates through five divisions of fit out, construction, infrastructure services, affordable housing and urban regeneration, which are supported by two specialist units of investments and professional services.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUURKRKBRURRA
Date   Source Headline
2nd Jun 202511:14 amRNSCompany Secretary Change
8th May 20258:36 amRNSAdditional Listing
7th May 20252:30 pmRNSHolding(s) in Company
1st May 202512:42 pmRNSResult of AGM
1st May 20259:30 amRNSTotal Voting Rights
1st May 20257:00 amRNSTrading Update
22nd Apr 20252:00 pmRNSCompany Secretary Change
22nd Apr 202510:11 amRNSBlock listing Interim Review
22nd Apr 20258:43 amRNSHolding(s) in Company
1st Apr 20259:38 amRNSTotal Voting Rights
27th Mar 20259:53 amRNSDirector/PDMR Shareholding
25th Mar 20251:50 pmRNSAdditional Listing
25th Mar 20257:00 amRNSTrading Update
24th Mar 20254:32 pmRNSHolding(s) in Company
20th Mar 20252:08 pmRNSAnnual Financial Report
14th Mar 202511:14 amRNSDirector/PDMR Shareholding
7th Mar 20251:33 pmRNSDirector/PDMR Shareholding
7th Mar 20251:26 pmRNSDirector/PDMR Shareholding
6th Mar 20254:42 pmRNSDirector/PDMR Shareholding
6th Mar 20254:38 pmRNSDirector/PDMR Shareholding
5th Mar 20258:56 amRNSDirector/PDMR Shareholding
3rd Mar 20259:41 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSResults for the Full Year Ended 31 December 2024
19th Feb 20253:20 pmRNSHolding(s) in Company
11th Feb 202512:00 pmRNSAppointment of Joint Corporate Broker
7th Feb 20252:37 pmRNSHolding(s) in Company
3rd Feb 202510:10 amRNSTotal Voting Rights
16th Jan 20257:07 amRNSDirector Declaration
16th Jan 20257:00 amRNSNotice of Full Year Results
15th Jan 20257:00 amRNSDirectorate Change
2nd Jan 202511:56 amRNSTotal Voting Rights
20th Dec 20243:54 pmRNSDirector/PDMR Shareholding
2nd Dec 202410:02 amRNSTotal Voting Rights
6th Nov 20241:18 pmRNSHolding(s) in Company
1st Nov 202410:33 amRNSTotal Voting Rights
30th Oct 20244:17 pmRNSDirector/PDMR Shareholding
28th Oct 20249:24 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update and Outlook for 2024
21st Oct 20249:27 amRNSBlock listing Interim Review
15th Oct 202412:22 pmRNSAdditional Listing
1st Oct 202412:09 pmRNSTotal Voting Rights
27th Sep 20242:46 pmRNSDirector/PDMR Shareholding
10th Sep 202411:44 amRNSAdditional Listing
2nd Sep 202410:45 amRNSTotal Voting Rights
30th Aug 202410:35 amRNSHolding(s) in Company
30th Aug 20249:29 amRNSDirector/PDMR Shareholding
23rd Aug 20242:48 pmRNSDirector/PDMR Shareholding
12th Aug 20249:52 amRNSHolding(s) in Company
9th Aug 20244:50 pmRNSHolding(s) in Company
8th Aug 20247:00 amRNSRESULTS FOR THE HALF YEAR (HY) ENDED 30 JUNE 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.